|
 |
 |
||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
||||
|
Home > Research X-Server-Uuid: E2E48A14-EE5B-4280-A138-188440602EDD X-WSS-ID: 6A2190CD0MC1485097-01-01 Approved-By: Rex Jones <rex.jones@RADIOLOGY.UCSF.EDU> Date: Mon, 7 May 2007 08:58:41 -0700 Reply-To: Rex Jones <rex.jones@radiology.ucsf.edu> Sender: "Radiology Dept. info on research matters" <RADFACULTY1@ITSSRV1.UCSF.EDU> Comments: RFC822 error: ignored. From: Rex Jones <rex.jones@radiology.ucsf.edu> Subject: UCSF Cancer Center Announcements Comments: To: Radiology Research <RADRESEARCH@itssrv1.ucsf.edu> To: RADFACULTY1@ITSSRV1.UCSF.EDU List-Help: List-Unsubscribe: List-Subscribe: List-Owner: Please see below for these announcements: -- CTSI Invites Proposals for Second Grant Cycle -- VisEn FMT System for IR Fluorescence Imaging of Whole Animals -- Funding Opportunity: Metastatic Colon Cancer Research -- 1st Int'l Costello Syndrome Research Symposium -- NIH Policy Update: Allowable Costs Involving Animals -- Offerings from Training in Clinical Research Program -- Last Chance to Register for Tobacco Documents Workshop -- Final Reminder: Breast Oncology Program Retreat -- June Offering by The Grant Institute ****************************************** John Mugge, Communications Manager UCSF Comprehensive Cancer Center Box 0128, San Francisco, CA 94143-0128 415.502.1986 (voice) | 353.7613 (fax) jmugge@cc.ucsf.edu http://cancer.ucsf.edu ****************************************** CTSI Invites Proposals for Second Grant Cycle June 4 is the next letter-of-intent deadline for award applications under the UCSF CTSI (Clinical and Translational Science Institute), sponsored by the project's Strategic Opportunities Support Center. In the first round of CTSI grant support, more than $1 million was awarded in April for 23 projects focusing on clinical and translational science activities. A second cycle will continue to support clinical and translational science by inviting proposals for these types of research projects: Investigator-initiated Pilot Awards in Clinical and Translational Research; Novel Clinical/Translational Methods Catalyst Awards; Translational Technology Awards; Multidisciplinary/Multicenter Research Project Planning Awards; Under-represented Faculty in Clinical and Translational Research Awards; and Flexible Mini-Sabbatical/Leave Awards. Second-round awards will be announced at the end of August. For more information and access to the online application process, visit http://www.sos.ucsf.edu. VisEn FMT System for IR Fluorescence Imaging of Whole Animals Max Krummel reports that the new Biological Imaging Development Center (Parnassus campus) is hosting a two-month implementation of a VisEn FMT system for IR fluorescence imaging of whole animals. The system has multiple applications for live imaging, particularly for imaging of tumors and inflammation, and it takes advantage of IR probes (e.g., for MMP detection). Other biological processes are also potentially applicable. For access to this equipment during its stay at the Center, consider attending the BIDC- and VisEn-sponsored Dynamics Imaging Group meeting on Wednesday, May 23, 5:30-6:30 pm, tentatively in HSW-1057 (venue confirmation will be posted shortly). Jeff Peterson, Sr. Dir of Applied Biology with VisEn Medical, will present a seminar, "In vivo Fluorescent Imaging of Mouse Disease Models." For PIs and postdocs who are certain of their interest, Jeff Peterson will be on-site on the afternoon of May 23 and the morning of May 24 to discuss how to get started. To schedule a consultation, send a message to bidc@ucsf.edu. VisEn guidelines and an instrument user guide can also be requested. Investigators who have specific questions not answered by the VisEn guidelines can contact Jess Kennedy directly at jkennedy@visenmedical.com. The Biological Imaging Development Center is online at http://pathology.ucsf.edu/BIDC. Funding Opportunity: Metastatic Colon Cancer Research The AACR is accepting applications for the 2007 Jeannik M. Littlefield-AACR Grants in Metastatic Colon Cancer Research, with an application deadline of June 26. The grants provide support for innovative projects designed to accelerate the discovery and development of new agents to treat metastatic colon cancer and/or for preclinical research with direct therapeutic intent. Special emphasis is placed on research that holds promise for leading to individualized therapeutic options in the near future or for developing promising new therapeutics for metastatic colon cancer that will translate into clinical applications within a one- to two-year period. Grants will be provided in an amount between $500,000 and $1 million, with three to five grants expected to be awarded this year. For information about eligibility, terms, and application instructions, visit the AACR website at http://www.aacr.org and enter the search term "Littlefield." Inquiries can be directed to Julia Laurence at awards@aacr.org. 1st Int'l Costello Syndrome Research Symposium The UCSF Comprehensive Cancer Center and the NIH (NICHD, NINDS, and ORD) are cosponsoring an international scientific meeting on Costello Syndrome, to be held July 21 at Oregon Health and Science University. The meeting is co-directed by UCSF faculty member Katherine Rauen, MD, PhD, and Lisa Schoyer, BA, MFA, president of the Costello Syndrome Family Network. Costello Syndrome is a complex developmental disorder involving characteristic craniofacial features, failure to thrive, developmental delay, cardiac and skeletal anomalies, and a predisposition to develop neoplasia, both benign and malignant. Recent molecular advances in the disease have included the discovery of HRAS as the causal gene; among the conference topics are an exploration of how causative mutations in HRAS alter protein function, and how this alteration may contribute to the pathogenesis of CS, as well as to understand the current state of Ras pathway inhibitors and to discuss their application in CS. Details on the conference are at http://www.cancer.ucsf.edu/costello2007. NIH Policy Update: Allowable Costs Involving Animals when Terms and Conditions are not Upheld Investigators who use animals in research are asked to note a new NIH policy (2/26/07) that provides guidance on allowable costs for grant activities involving animals. The notice clarifies that no costs for activities with live vertebrate animals may be charged to NIH in the absence of a valid IACUC approval, i.e., when activities have not been approved by the IACUC or when approval has expired or is under suspension. ("NIH expects grantees to continue to maintain and care for animals during the periods described above. Funding components may allow expenditure of NIH grant funds for maintenance and care of animals on a case-by-case basis.") PIs must report such situations to the Institute/Center supporting the award and notify the IACUC that this has been done. The notice is at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-044.html. Offerings from Training in Clinical Research Program The UCSF Training in Clinical Research Program has announced opportunities for scholars who desire to develop and enhance their skills in clinical research. -- The Summer Clinical Research Workshop, to be held on Tuesday and Thursday mornings for seven weeks beginning July 31, includes three courses: Designing Clinical Research (Epi 202); Responsible Conduct of Research (Epi 201); and Building a Career in Clinical Research (Epi 227). The registration deadline is July 13. -- The year-long Advanced Training in Clinical Research Certificate Program includes the Summer Clinical Research Workshop and continues on Tuesdays and Thursdays from September through June. The ATCR Program is a four-quarter didactic sequence where, in addition to required coursework, scholars are expected to develop and implement a clinical research project. The application deadline is June 1. Early application is strongly encouraged for both offerings. Application forms and details are available at http://www.epibiostat.ucsf.edu/courses/post.html. Last Chance to Register for UCSF Tobacco Documents Workshop May 18 is the application deadline for the 2007 Tobacco Documents Workshop, "Putting the Tobacco Industry's Words to Work for You," to be held on June 23 at the Parnassus campus. The annual workshop on using tobacco industry documents for advocacy is offered by the UCSF Center for Tobacco Control Research and Education. It will include an introduction to tobacco industry documents databases; hands-on practice searching and extracting key industry documents under the supervision of expert documents researchers; examples of ways in which the documents can be of use to promote tobacco-free communities; and opportunities to network and brainstorm with top documents researchers and other advocates. A $25 registration fee is refundable upon completion of workshop. For details and registration, contact Jenni Alexander at Jenni.Alexander@ucsf.edu or 502-6341. Final Reminder: Breast Oncology Program Retreat Organizers of the May 11 retreat for the UCSF Breast Oncology Program remind late responders to complete their registration by Monday, May 7. Only a few slots are still available for poster submission. For all information, visit the retreat website at http://cancer.ucsf.edu/research/BOP2007. June Offering of Grant Proposal Workshop by The Grant Institute The Grant Institute will offer its Certificate in Professional Program Development and Grant Communication June 11-15 at UCSF. The workshop is intended for development professionals, researchers, faculty, and graduate students. During the five-day course, participants are led through an interactive regimen of program development, grant writing, and funding acquisition processes. Tuition is $997.00, inclusive of all materials and certificates. Participants will receive certification in professional grant writing as well as 3.5 CEU units. For more information, visit http://www.thegrantinstitute.com or call 888/824-4424. -- Rex Jones Research Administrator Department of Radiology University of California, San Francisco 3333 California Street, Suite 375 San Francisco, CA 94143-0629 Tel: 415-502-8700 Fax: 415-502-7493 |
|
|
|
|
|
|
|
|
|
